Diabetes News and Facts About Diabetes And Weight Loss

Diabetic News and information on diabetes and weight loss: Update 1/6/2010

The basis for this information comes from leading articles, news release and press releases. The primary source for this information comes from researching the terms "diabetes is" online. There were hundreds of quality responses included in this information along with current press releases and media news. In all cases the original content is intact and in some cases they mentioned their company name or affiliation. When the source was mentioned I left it in.

Saving healthcare dollars and millions of lives is the headline starting off the new year. Pharmaceutical reporter Mike Huckman, CNBC Exclusive report exclusive. He goes on to say, the annual obesity society meeting, 2550 attendees from all over the world were buzzing about three potential diet pills that could be in front of the FDA soon.

Dr; Louis Aroney is the leading obesity expert director of weight control program at NY Presbyterian Hospital. Dr. Aronne is mentioned with Cornell Medical College. His story is all about the numbers. The average obese person according to Dr. Aroney weights 220 pounds and is on 7 medications for diabetes, weight loss and cholesterol. He's all for new ways to reduce both the weight of the obese as well as lower the number of prescription medicines they take.

He claims" The field needs to develop room for medication, people benefit from it. In synopsis he advises: mix and use different ones, trying different ones. No one script works for everyone. Taking one or two medicines for their weight makes a lot of sense. The premise if they can get people to lose weight with 1 or 2 of these new drugs we will save money health care dollars.

He hoes on to advise,: "it is extremely important that weight medication is included in health as well as in medi-care and medi-cade reform bill. Fact is there are physical mechanisms that make it difficult for people to lose weight once they gain weight. It's a disease rather than a lack of will power."

Headline story on these three new drugs: the average stats from late date clinical trials:
1- Qnexa is the name of the drug and it is from Vivas
2- Contrave is the name of the drug and it is from Arexian
3- Lorcaserin is the name of the drug and it is from Arean Pharmaceuticals

Always check new findings and new drugs with your medical doctor first even when considering over the counter supplements or any change in your normal diet activities.

___________________________________________________________

Diabetes New Release:

PRINCETON, NJ (November 27, 2009) - The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.

According to the forecast, the number of Americans living with diabetes will rise from 23.7 million in 2009 to 44.1 million in 2034. For the Medicare program, the increases over the next 25 years are even more dramatic: the number of Americans living with diabetes and covered by Medicare will rise from 6.5 million to 14.1 million, and Medicare spending on diabetes will almost quadruple, skyrocketing from $45 billion this year to $171 billion in 2034. Based on this projection, "Medicare spending alone will represent just over 50% of direct spending on diabetes in 2034," the authors concluded.

Unlike past efforts to predict trends in diabetes, the model developed by the University of Chicago team considers the natural progression of the disease, effects of treatment and obesity rates in the United States, which are "factors that are currently not used by government budget analysts," according to the authors.

"Obesity is a significant driver of future increases in the number of Americans with diabetes," said Michael O'Grady, Ph.D., one of the study authors and a senior fellow at the National Opinion Research Center at the University of Chicago. "While our modeling, as well as that done by the Centers for Disease Control and Prevention, project obesity rates leveling off, neither model has obesity rates lowering substantially. High obesity rates among the American population over an extended period of time substantially increases the probability of developing type 2 diabetes."
This forecasting model, which the authors contend improves the rigor of the estimates of health care spending for diabetes, was designed to inform policymakers as they explore ways to control spiraling health care costs. Currently, official government estimates of the potential costs and cost offsets associated with proposed preventive health legislation do not consider savings that may occur more than 10 years out, thus providing an incomplete view of preventive health measures as an investment.

"The size of the current diabetes population exceeds many prior forecasts and we expect that the future growth of population and its associated costs will be explosive. Finding ways to reduce the number of people who develop diabetes is both a national public health priority and a fiscal imperative," said Dr. Elbert Huang, the lead author of the paper and an assistant professor of medicine in the Department of Medicine at the University of Chicago. "The best way to stem the dramatic rise in diabetes is to implement proven preventive care programs on a national level. This will require that policymakers understand that diabetes prevention is a long-term investment that will only reap benefits over decades, not years."

The Congressional Budget Office (CBO), which assesses the cost of proposed legislation, does not typically consider any cost savings beyond 10 years. Because diabetes develops over a long period of time, with the highest costs coming later in life of the disease, savings are far more apparent at 25 years than at 10 years. For this reason, policymakers need a long-term analysis of costs in order to make accurate decisions that reflect the true impact of prevention programs.
"Managing diabetes means preventing the pain and expense of diabetes complications, including heart disease, amputation, kidney disease, and blindness," said Michael Mawby, Chief Government Affairs Officer and director of the NCDP, a diabetes leadership initiative established by Novo Nordisk to drive health systems change at the national and local level, which funded the research. "Therefore, it is critical that lawmakers see the long-term projections of the impact of diabetes interventions."

________________Printed in its entirety, source unknown_____________________________

More news and information on diabetes and weight loss

Go directly to beverages for diabetics

Go directly to non-alcoholic beverages and alcohol free drinks for diabetics

0 calories
0 carbohydrates
0 fats
0 salt

Weight Loss
Diabetes

Stevia Natural Sweetener is great for"

Diabetics
Weight Loss (Stevia logo image)
For baking and cooking and is heat Stable to 390 degrees
Naturally sweetening foods and beverages

Go back to Dieticians and Nutritionists, including Consumer Articles and Publications

Go to homepage and start at the beginning to learn more...